IP Library Granted Patent US 7,691,363
Granted Patent B2
US 7,691,363 · App. 10/859,533 · Granted Apr 6, 2010

Compositions containing phenethyl aryl esters as solubilizing agents for active organic compounds

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,691,363
App. No.
10/859,533
Granted
Apr 6, 2010
Kind
B2
Abstract

An active or functional organic compound is solubilized in a phenylethyl ester, e.g. an aryl carboxylic ester of 2-phenylethyl alcohol, as a solvent, cosolvent or additive, to form a composition thereof. Representative active or functional organic compounds include personal care products, e.g. sunscreens containing UVA/UVB absorbing compounds, such as avobenzone and benzophenone-3. Such compositions also show increased critical wavelength and UVA/UVB absorbance ratio performance properties.

Claims (18)

1. A sunscreen composition of an active or functional organic compound solubilized in a phenylethyl ester which is an aryl carboxylic ester of 2-phenylethyl alcohol.

2. A composition according to claim 1 wherein said phenylethyl ester is 2-phenylethyl benzoate, 2-phenylethyl toluate or di-2-phenylethyl phthalate.

3. A composition according to claim 1 in which said active compound is a solid organic compound.

4. A composition according to claim 1 wherein said active or functional compound is a personal care, cosmetic, pharmaceutical, agricultural or industrial compound.

5. A sunscreen composition according to claim 1 containing UVA and/or UVB chemical compounds, which in said sunscreen composition shows increased critical wavelength and UVA/UVB absorbance ratio.

6. A sunscreen composition according to claim 1 in which said active compound is solubilized in an amount of at least 20% w/w.

7. A sunscreen composition according to claim 1 in which said actives are avobenzone or benzophenone-3.

8. A sunscreen composition according to claim 6 in which said actives are avobenzone or benzophenone-3.

9. A sunscreen composition according to claim 1 in which said actives are selected from the group consisting of avobenzone, benzophenone-3, p-Aminobenzoic acid (PABA), Camphor benzalkonium methosulfate, Homosalate, Phenylbenzimidazole sulfonic acid, Terephthalidene dicamphor sulfonic acid, Benzylidene camphor sulfonic acid, Octocrylene, Polyacrylamidomethyl benzylidene camphor, Ethylhexyl methoxycinnamate, PEG-25 PABA, Isoamyl p-methoxycinnamate, Ethylhexyl triazone, Drometrizole trisiloxane, Diethylhexyl butamido triazone, 4-Methylbenzylidene camphor, 3-Benzylidene camphor, Ethylhexyl salicylate, Ethylhexyl dimethyl PABA, Benzophenone-4, Benzophenone-5, Methylene bis-benztriazolyl tetramethylbutylphenol, Disodium phenyl dibenzimidazole tetrasulfonate, Bisethylhexyloxyphenol methoxyphenol triazine, Polysilicone-15, and mixtures thereof.

10. A sunscreen composition according to claim 6 in which said actives are selected from the group consisting of avobenzone, benzophenone-3, p-Aminobenzoic acid (PABA), Camphor benzalkonium methosulfate, Homosalate, Phenylbenzimidazole sulfonic acid, Terephthalidene dicamphor sulfonic acid, Benzylidene camphor sulfonic acid, Octocrylene, Polyacrylamidomethyl benzylidene camphor, Ethylhexyl methoxycinnamate, PEG-25 PABA, Isoamyl p-methoxycinnamate, Ethylhexyl triazone, Drometrizole trisiloxane, Diethylhexyl butamido triazone, 4-Methylbenzylidene camphor, 3-Benzylidene camphor, Ethylhexyl salicylate, Ethylhexyl dimethyl PABA, Benzophenone-4, Benzophenone-5, Methylene bis-benztriazolyl tetramethylbutylphenol, Disodium phenyl dibenzimidazole tetrasulfonate, Bisethylhexyloxyphenol methoxyphenol triazine, Polysilicone-15, and mixtures thereof.

11. A composition according to claim 1 wherein said active or organic functional compound is selected from the group consisting of Furosemide, Lovastatin, Clarithromycin, Diclofenac, Famotidine, Carbamaxepine, Dipyridamole, Chlorthiazide, Spironolactone, Phenytoin, Imipramine, Mefloquine, Cyclosporine, Glyburide, Nimodipine, and mixtures thereof.

12. A composition according to claim 1 wherein said active or organic functional compound is selected from the group consisting of cosmetic, pharmaceutical, agricultural, industrial compounds.

13. A composition according to claim 1 comprising at least two active or organic functional compounds selected from the group consisting of UV-filter, cosmetic, and pharmaceutical compounds.

14. A composition according to claim 1 comprising a UV-filter compound and a pharmaceutical compound.

15. A composition according to claim 14 comprising a UV-filter compound selected from the group consisting of avobenzone, benzophenone-3, p-Aminobenzoic acid (PABA), Camphor benzalkonium methosulfate, Homosalate, Phenylbenzimidazole sulfonic acid, Terephthalidene dicamphor sulfonic acid, Benzylidene camphor sulfonic acid, Octocrylene, Polyacrylamidomethyl benzylidene camphor, Ethylhexyl methoxycinnamate, PEG-25 PABA, Isoamyl p-methoxycinnamate, Ethylhexyl triazone, Drometrizole trisiloxane, Diethylhexyl butamido triazone, 4-Methylbenzylidene camphor, 3-Benzylidene camphor, Ethylhexyl salicylate, Ethylhexyl dimethyl PABA, Benzophenone-4, Benzophenone-5, Methylene bis-benztriazolyl tetramethylbutylphenol, Disodium phenyl dibenzimidazole tetrasulfonate, Bisethylhexyloxyphenol methoxyphenol triazine, Polysilicone-15, and mixtures thereof, and a pharmaceutical compound selected from the group consisting of Furosemide, Lovastatin, Clarithromycin, Diclofenac, Famotidine, Carbamaxepine, Dipyridamole, Chlorthiazide, Spironolactone, Dilantin, Imipramine, Mefloquine, Cyclosporine, Glyburide, Nimodipine, and mixtures thereof.

16. A sunscreen or sunscreen-containing formulation comprising an active or functional organic compound solubilized in a phenylethyl ester which is an aryl carboxylic ester of 2-phenylethyl alcohol.

17. A formulation according to claim 16 which is a personal care, cosmetic, pharmaceutical, agricultural or industrial formulation.

18. A composition according to claim 1 which effectively delivers said compound.

Assignments (2)
RELEASE OF SECURITY INTEREST Recorded Jan 10, 2020
From: THE BANK OF NOVA SCOTIA
To: AVOCA LLC; HERCULES LLC; ISP INVESTMENTS LLC; PHARMACHEM LABORATORIES LLC
Reel/Frame 051557/0504 →
CONVERSION Recorded Jan 30, 2017
From: ISP INVESTMENTS INC.
To: ISP INVESTMENTS LLC
Reel/Frame 041556/0499 →